Related Experiment Video
Updated: Jul 31, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Prevention and Screening for Cardiometabolic Disease Following Hypertensive Disorders in Pregnancy in Low-Resource
Salisu Mohammed Ishaku1, Kwame Adu-Bonsaffoh2,3, Natasha Housseine2,4
1Julius Global Health, Julius Center for Health Science and Primary Care, University Medical Center, Utrecht, NL.
Insights
Hypertensive disorders in pregnancy (HDP) increase the risk of cardiometabolic and kidney diseases. This study developed 33 practical, scalable recommendations for screening and prevention in low- and middle-income countries (LMICs).
Area of Science:
- Public Health
- Cardiology
- Nephrology
Background:
- Hypertensive disorders in pregnancy (HDP) are increasing in low- and middle-income countries (LMICs) and are known risk factors for future cardiometabolic and kidney diseases.
- Effective, scalable, and cost-effective strategies for screening and prevention in women with a history of HDP are lacking in LMIC settings.
- Existing international guidelines require adaptation to suit the specific contexts and resource limitations of LMICs.
Approach:
- A systematic review of guidelines and recommendations for the prevention and screening of cardiometabolic and chronic kidney diseases post-HDP was conducted.
- Literature searches were performed in PubMed/Medline, Embase, and Cochrane Library for articles and guidelines published between 2010 and 2021.
- Findings were synthesized, and a summary of recommendations underwent two rounds of Delphi consensus surveys with experts experienced in LMIC settings.
Key Points:
- Thirty-five clinical recommendations were synthesized across six domains: identification of women with HDP, counseling and health education timing, care structure and setting, information needs, and cardiometabolic and biomarker thresholds.
- The Delphi panel achieved consensus on 33 final recommendations.
- These recommendations offer practical and scalable approaches for health workers in LMICs.
Conclusions:
- The developed recommendations provide a framework for effective screening and prevention of cardiometabolic diseases following HDP in LMICs.
- Implementation and evaluation of these recommendations can help mitigate the growing burden of noncommunicable diseases in these regions.
- Tailored strategies are crucial for managing long-term health risks associated with HDP in resource-limited settings.
Abstract:
Hypertensive disorders in pregnancy (HDP) and cardiometabolic and kidney diseases are rising in low- and middle-income countries (LMICs). While HDP are risk factors for cardiometabolic and kidney diseases, cost-effective, scalable strategies for screening and prevention in women with a history of HDP are lacking. Existing guidelines and recommendations require adaptation to LMIC settings. This article aims to generate consensus-based recommendations for the prevention and screening of cardiometabolic and kidney diseases tailored for implementation in LMICs. We conducted a systematic review of guidelines and recommendations for prevention and screening strategies for cardiometabolic and chronic kidney diseases following HDP. We searched PubMed/Medline, Embase and Cochrane Library for relevant articles and guidelines published from 2010 to 2021 from both high-income countries (HICs) and LMICs. No other filters were applied. References of included articles were also assessed for eligibility. Findings were synthesized narratively. The summary of guiding recommendations was subjected to two rounds of Delphi consensus surveys with experts experienced in LMIC settings. Fifty-four articles and 9 guidelines were identified, of which 25 were included. Thirty-five clinical recommendations were synthesized from these and classified into six domains: identification of women with HDP (4 recommendations), timing of first counseling and provision of health education (2 recommendations), structure and care setting (12 recommendations), information and communication needs (5 recommendations), cardiometabolic biomarkers (8 recommendations) and biomarkers thresholds (4 recommendations). The Delphi panel reached consensus on 33 final recommendations. These recommendations for health workers in LMICs provide practical and scalable approaches for effective screening and prevention of cardiometabolic disease following HDP. Monitoring and evaluation of implementation of these recommendations provide opportunities for reducing the escalating burden of noncommunicable diseases in LMICs.
Related Concept Videos
Hypertension V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Preventive Healthcare Services
Errors occurring during blood pressure monitoring
Several factors...
Hypertension and Regulation of Blood Pressure

